The protease inhibitor is specifically intended for non-hospitalized, symptomatic adults who have a confirmed COVID-19 infection and are not believed to be at increased risk for progression to severe illness. A controlled study is underway.
Recommended.
Read Our Latest News
Do you like this post?
Showing 1 reaction
Sign in with